As with all research peptides, the information presented here is educational in nature and does not constitute medical advice
The randomized SELECT trial already showed that semaglutide 2.4 mg cuts major cardiovascular events by 20% versus placebo in patients with overweight or obesity and prior CVD, without diabetes
Malhotra A et al., SURMOUNT-OSA, NEJM 2024 (NEJMoa2404881, PMID 38912654) : tirzepatide and obstructive sleep apnea, AHI -25,3 to 52 weeks
Store in the refrigerator when not in use, and avoid excessive heat
The four data points that matter most: Severity (110) of any GI symptom that day Day of dose cycle (day 1 = injection day) What you ate and at what time (especially fat content) Hydration, alcohol, caffeine, and sleep hours Consider an OTC option (with a clinician check first)
What are 503B outsourcing facilities, and what role do they play in our healthcare system